TitletownTech — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection.
BiotechHealthtechMedical DevicesCharlottesville, US
Co-investorsVirginia Venture Partners
Madison, US
Aishwarya Das(Mr. Das is the Chief Operating Officer)Sanket Deshpande(Executive Officer, Director)
Co-investorsAutomotive Ventures MobilityAutomotive VenturesgradCapitalquantumEDGE Ventures
Shelfmark provides AI-based visual inspection systems that detect, predict, and prevent defects in continuously manufactured "web-based" rolled goods such as textiles, webbings, labels, films, trusses, and coil coatings.
Advanced ManufacturingAI & Machine LearningHardwarePittsburgh, US
Patrick O'Donnell(Executive Officer, Director, Promoter)PatinCraig Markovitz(Executive Officer, Director)in
BoardAnthony Santaro(Director)in
Co-investorsArmory Square Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.